Long-term study of hard-to-treat inflammatory bowel disease
Part of Digestive system clinical trials.
This study follows people with hard-to-treat Crohn's disease, ulcerative colitis, or unclassified IBD over time to learn more about the disease and its treatments. It aims to improve care for patients who haven't responded well to standard therapies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years old or older.
- You have a confirmed diagnosis of Crohn's disease, ulcerative colitis, or IBD unclassified.
- You receive your care at one of the participating hospitals.
- If you are on advanced therapies (like biologics), details of your treatment must be available.
- You meet at least one of the special 'difficult-to-treat' criteria, such as failed medical treatment, complex fistulas, or pouch-related issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with Crohn's disease that is hard to treat. It aims to understand the disease better and see how well current treatments work.
This study looks at what factors help predict how inflammatory bowel disease (IBD) may progress over time. You may be able to join if you are an adult with IBD and fit one of the study groups based on whether you have used TNF-blocking medicines before.
This trial collects information from children who are newly diagnosed with inflammatory bowel disease (IBD) and follows them to understand safety in real life. It may help doctors improve early diagnosis and treatment planning for kids with IBD.
This study looks at people with active Crohn's disease or ulcerative colitis starting a new type of medication (anti-TNF, ustekinumab, upadacitinib, or vedolizumab), as well as people without IBD having a routine colonoscopy. It aims to collect information to better understand how these treatments work.
This study collects blood, stool, tissue, and health information from people with inflammatory bowel disease (IBD), their relatives, and healthy volunteers to find patterns that may help diagnose or treat IBD better in the future.
This study tests a new care program designed to help people with inflammatory bowel disease (IBD) manage their condition better and improve their quality of life. If you join, you'll receive extra support and training to help you cope with your symptoms and daily life.
Hear when a new Inflammatory Bowel Diseases (IBD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.